By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Akorn, Inc. 

1925 West Field Court

Lake Forest  Illinois  60045  U.S.A.
Phone: 847-279-6100 Fax: 847-236-3823



Drug Discovery

Company News
Akorn (AKN) Shareholders Vote To Approve Merger Agreement With Fresenius Kabi AG 7/20/2017 11:17:13 AM
U.S. Generic Drugmaker Akorn (AKN) Surges On Reports Fresenius SE Is Interested 4/10/2017 7:21:53 AM
Akorn, Inc. (AKN) Receives FDA Approval For Ephedrine Sulfate Injection, USP 3/2/2017 8:13:10 AM
Akorn, Inc. (AKN) Receives Approval For Mycophenolate Mofetil For Injection, USP 3/1/2017 11:33:22 AM
Akorn, Inc. (AKN) Provides Fourth Quarter And Full Year 2016 Results And Outlines Full Year 2017 Guidance 3/1/2017 11:20:49 AM
Akorn, Inc. (AKN) To Report Fourth Quarter And Full Year 2016 Results 2/6/2017 10:44:10 AM
Akorn, Inc. (AKN) Announces Completion Of FDA Re-Inspection Of Decatur Facility 12/12/2016 7:51:45 AM
Akorn, Inc. (AKN) Invalidates Durezol Patent Via Inter Partes Review Proceeding 11/29/2016 8:21:57 AM
Akorn, Inc. (AKN) Launches Ibuprofen Oral Suspension 11/29/2016 8:11:05 AM
Akorn, Inc. (AKN) Provides Third Quarter 2016 Results 11/3/2016 9:14:26 AM